Blerdi Blakaj

Blerdi Blakaj is a researcher at Erasmus University Medical Center (Erasmus MC) in Rotterdam, Netherlands, specializing in immunology and microbiome science. His work focuses on clinical-translational research involving vulnerable populations, particularly people living with HIV, and spans infectious disease immunology, vaccinology, and microbiome-disease interactions.

His primary research domains include HIV immunogenicity, COVID-19 vaccine responses in immunocompromised patients, and microbiome alterations in colorectal cancer and psoriasis. This multidisciplinary approach integrates clinical immunology, virology, and microbial ecology to address therapeutic challenges in chronic diseases and vaccine efficacy.

Publication analysis reveals consistent emphasis on real-world vaccine performance in HIV populations and host-microbe interactions in inflammatory conditions. His 2024 studies on bivalent mRNA boosters demonstrate expertise in clinical immunology, while earlier microbiome work shows methodological innovation in diagnostic screening and dermatological therapeutics.

Though specific grant details and mentoring activities aren't documented in available sources, his extensive co-authorship across virology, gastroenterology, and dermatology journals indicates robust cross-departmental collaboration within Erasmus MC's research ecosystem.